Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Short-term pharmacological activation of Nrf2 ameliorates vascular dysfunction in aged rats and in pathological human vasculature. A potential target for therapeutic intervention.

Angulo J, El Assar M, Sevilleja-Ortiz A, Fernández A, Sánchez-Ferrer A, Romero-Otero J, Martínez-Salamanca JI, La Fuente JM, Rodríguez-Mañas L.

Redox Biol. 2019 Jul 5;26:101271. doi: 10.1016/j.redox.2019.101271. [Epub ahead of print]

2.

Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma.

González J, Gaynor JJ, Martínez-Salamanca JI, Capitanio U, Tilki D, Carballido JA, Chantada V, Daneshmand S, Evans CP, Gasch C, Gontero P, Haferkamp A, Huang WC, Espinós EL, Master VA, McKiernan JM, Montorsi F, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vera-Donoso C, Zigeuner R, Hohenfellner M, Libertino JA, Ciancio G.

Eur J Surg Oncol. 2019 May 15. pii: S0748-7983(19)30447-0. doi: 10.1016/j.ejso.2019.05.009. [Epub ahead of print]

PMID:
31155470
3.

Optimizing collagenase Clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling.

Fernández-Pascual E, González-García FJ, Angulo J, Cerezo E, Quintana LM, Turo J, Martínez-Ballesteros C, Carballido J, Martínez-Salamanca JI.

BJU Int. 2019 Apr 29. doi: 10.1111/bju.14784. [Epub ahead of print]

PMID:
31033130
4.

Salvage robot-assisted radical prostatectomy following failed local treatments.

Linares Espinós E, Ogaya-Piniés G, Martínez-Salamanca JI.

Arch Esp Urol. 2019 Apr;72(3):277-282.

PMID:
30945654
5.

Future of focal therapy for the treatment of prostate cancer- european section of urotechnology (ESUT) position.

Barret E, Ganzer R, Salomon G, Fielder M, Celia A, Enikeev D, Martínez-Salamanca JI, Liatsikos E, Gómez Rivas J.

Arch Esp Urol. 2019 Mar;72(2):167-173. Review.

PMID:
30855018
6.

Sildenafil/Viagra in the treatment of premature ejaculation.

Krishnappa P, Fernandez-Pascual E, Carballido J, Martinez-Salamanca JI.

Int J Impot Res. 2019 Mar;31(2):65-70. doi: 10.1038/s41443-018-0099-2. Epub 2019 Mar 5. Review.

PMID:
30837718
7.

Surgical Technique for Complex Cases of Peyronie's Disease With Implantation of Penile Prosthesis, Multiple Corporeal Incisions, and Grafting With Collagen Fleece.

Fernández-Pascual E, Gonzalez-García FJ, Rodríguez-Monsalve M, Turo J, Martínez-Ballesteros C, Carballido J, Martínez-Salamanca JI.

J Sex Med. 2019 Feb;16(2):323-332. doi: 10.1016/j.jsxm.2018.11.014.

PMID:
30770074
8.

Efficacy and safety of artificial urinary sphincter (AUS): Results of a large multi-institutional cohort of patients with mid-term follow-up.

Tutolo M, Cornu JN, Bauer RM, Ahyai S, Bozzini G, Heesakkers J, Drake MJ, Tikkinen KAO, Launonen E, Larré S, Thiruchelvam N, Lee R, Li P, Favro M, Zaffuto E, Bachmann A, Martinez-Salamanca JI, Pichon T, De Nunzio C, Ammirati E, Haab F, Van Der Aa F.

Neurourol Urodyn. 2019 Feb;38(2):710-718. doi: 10.1002/nau.23901. Epub 2018 Dec 21.

PMID:
30575997
9.

Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study.

Moncada I, Krishnappa P, Romero J, Torremade J, Fraile A, Martinez-Salamanca JI, Porst H, Levine L.

BJU Int. 2019 Apr;123(4):694-702. doi: 10.1111/bju.14602. Epub 2018 Nov 22.

PMID:
30365247
10.

Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil.

Moncada I, Martinez-Salamanca J, Ruiz-Castañe E, Romero J.

Int J Impot Res. 2018 Oct;30(5):203-208. doi: 10.1038/s41443-018-0046-2. Epub 2018 Jul 26. Review.

PMID:
30050072
11.

Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort.

Marra G, Gontero P, Brattoli M, Filippini C, Capitanio U, Montorsi F, Daneshmand S, Huang WC, Linares Espinós E, Martínez-Salamanca JI, McKiernan JM, Zigeuner R, Libertino JA.

Urol Oncol. 2018 Jul;36(7):339.e1-339.e8. doi: 10.1016/j.urolonc.2018.04.007. Epub 2018 May 24.

PMID:
29801993
12.

New technologies and techniques for prostate cancer focal therapy.

Linares-Espinós E, Carneiro A, Martínez-Salamanca JI, Bianco F, Castro-Alfaro A, Cathelineau X, Valerio M, Sanchez-Salas R.

Minerva Urol Nefrol. 2018 Jun;70(3):252-263. doi: 10.23736/S0393-2249.18.03094-1. Epub 2018 Apr 16. Review.

13.

Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Tilki D, Chandrasekar T, Capitanio U, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Linares Espinós E, Lorentz A, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vera-Donoso C, Zigeuner R, Libertino JA, Evans CP.

Urol Oncol. 2018 Feb;36(2):79.e11-79.e17. doi: 10.1016/j.urolonc.2017.10.008. Epub 2017 Nov 10.

PMID:
29129353
14.

Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).

Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M, Romero-Otero J, Martinez-Salamanca JI, Jones TH, Debruyne FMJ, Kurth KH, Hackett GI, Quinton R, Stroberg P, Reisman Y, Pescatori ES, Morales A, Bassas L, Cruz N, Cunningham GR, Wheaton OA; RHYME Investigators.

J Sex Med. 2017 Sep;14(9):1104-1115. doi: 10.1016/j.jsxm.2017.07.004. Epub 2017 Aug 7.

PMID:
28781213
15.

Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.

Rodriguez Faba O, Linares E, Tilki D, Capitanio U, Evans CP, Montorsi F, Martínez-Salamanca JI, Libertino J, Gontero P, Palou J.

Eur Urol Focus. 2018 Apr;4(3):435-441. doi: 10.1016/j.euf.2017.01.009. Epub 2017 Feb 9.

PMID:
28753848
16.

α1A-Adrenergic Receptor Antagonism Improves Erectile and Cavernosal Responses in Rats With Cavernous Nerve Injury and Enhances Neurogenic Responses in Human Corpus Cavernosum From Patients With Erectile Dysfunction Secondary to Radical Prostatectomy.

Martínez-Salamanca JI, La Fuente JM, Martínez-Salamanca E, Fernández A, Pepe-Cardoso AJ, Louro N, Carballido J, Angulo J.

J Sex Med. 2016 Dec;13(12):1844-1857. doi: 10.1016/j.jsxm.2016.10.005. Epub 2016 Nov 15.

PMID:
27864032
17.

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.

Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA, McKiernan JM, Libertino JA, Haferkamp A; International Renal Cell Carcinoma-Venous Thrombus Consortium, Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Hohenfellner M, Huang WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A, Martínez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, O'Malley P, Pahernik S, Palou J, Moreno JL, Pruthi RS, Faba OR, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Tilki D, Vázquez-Martul D, Donoso CV, Vergho D, Wallen EM, Zigeuner R.

J Surg Oncol. 2016 Nov;114(6):764-768. doi: 10.1002/jso.24395. Epub 2016 Aug 26.

18.

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).

Maggi M, Wu FC, Jones TH, Jackson G, Behre HM, Hackett G, Martin-Morales A, Balercia G, Dobs AS, Arver ST, Maggio M, Cunningham GR, Isidori AM, Quinton R, Wheaton OA, Siami FS, Rosen RC; RHYME Investigators.

Int J Clin Pract. 2016 Oct;70(10):843-852. doi: 10.1111/ijcp.12876.

PMID:
27774779
19.

Focalyx Dx, Bx, Tx et Apps: A novel contemporary fusion paradigm for the management of prostate cancer.

Bianco FJ, Martínez-Salamanca JI.

Arch Esp Urol. 2016 Jul;69(6):353-63. Review.

PMID:
27416639
20.

Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.

Debruyne FM, Behre HM, Roehrborn CG, Maggi M, Wu FC, Schröder FH, Jones TH, Porst H, Hackett G, Wheaton OA, Martin-Morales A, Meuleman E, Cunningham GR, Divan HA, Rosen RC; RHYME Investigators.

BJU Int. 2017 Feb;119(2):216-224. doi: 10.1111/bju.13578. Epub 2016 Aug 14.

Supplemental Content

Loading ...
Support Center